News Features Chaos and Questions: New Public-Access Policies Put Journals in Flux Michael O'Riordan August 14, 2023
News Daily News CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally Michael O'Riordan December 14, 2022
News Daily News Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks Michael O'Riordan October 07, 2022
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Opinion Editor's Corner EuroPCR 2022 EuroPCR Kicks Off In Person Next Week in Paris: Here’s What to Expect Shelley Wood May 12, 2022
News Daily News Could a Coronary Calcium Test Rule Out CAD in Chest Pain? Michael O'Riordan October 21, 2021
News Conference News EAS 2021 High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI Michael O'Riordan June 08, 2021
News Industry News SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz July 11, 2019
News Conference News ACC 2018 My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up Shelley Wood March 27, 2018
News Daily News Platelet Reactivity High in Most Patients Who Develop Stent Thrombosis L.A. McKeown December 20, 2017
News Features Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions Michael O'Riordan May 08, 2017
News Daily News Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings Michael O'Riordan July 12, 2016
News Daily News Medical Devices Approved More Quickly in EU Face More Safety Alerts and Recalls Shelley Wood July 05, 2016
News Daily News Los Dispositivos Médicos Aprobados Más Rápidamente en la UE son Objeto de Más Alertas de Seguridad y Nuevas Inspecciones Shelley Wood July 05, 2016
News Conference News EuroPCR 2016 Sex Disparities in MI Care Are Narrowing, but There’s Still a Long Way to Go Caitlin E. Cox May 25, 2016
News Daily News Amid Soaring CAD in China, Rates of Catheterization and PCI Begin to Mount Leah Lawrence March 18, 2016
News Industry News Brilique (ticagrelor) approved in EU for extended treatment of patients with history of heart attack February 18, 2016